Literature DB >> 22196388

Surgical site infection prevention initiative - patient attitude and compliance.

Nicholas Ramos1, Faith Skeete, Janet P Haas, Lorraine Hutzler, James Slover, Michael Phillips, Joseph Bosco.   

Abstract

BACKGROUND: Although the effect of Staphylococcus aureus (SA) decolonization on surgical site infection (SSI) rates has been studied, patient tolerance and acceptance of these regimens has not been assessed. Surgical patients at our hospital's Pre-Admission Testing Clinic (PAT) receive SA reduction protocols instructing the preoperative use of chlorhexidine gluconate (CHG) soap and intranasal mupirocin ointment (MO). Certain insurers do not cover MO costs resulting in out of pocket (OOP) expenses for some patients.
OBJECTIVE: This study assessed patient attitudes and compliance with our hospital's SA decolonization regimen.
METHODS: One-hundred-forty-six patients received surveys. Descriptive statistics were used for analysis.
RESULTS: Of respondents fitting inclusion criteria, 81% followed the MO protocol (MO users) while 89% followed the CHG protocol (CHG users). Fifty-four percent of MO users reported OOP expenses and 13% reported a hard or very hard financial burden. Ninety-three percent of CHG users reported the protocol was easy or very easy to follow.
CONCLUSION: Eighty-one percent of patients receiving the SA protocol were fully compliant despite cost or difficulty obtaining MO. Given these barriers and some difficulty with CHG application, we hypothesize compliance may be improved if MO is provided to patients without OOP expenses and if the CHG application method is simplified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22196388

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  9 in total

1.  [Infections in trauma and orthopedic surgery].

Authors:  K Dresing
Journal:  Oper Orthop Traumatol       Date:  2013-06       Impact factor: 1.154

2.  Preoperative decolonization to reduce infections in urgent lower extremity repairs.

Authors:  Daniel S Urias; Merin Varghese; Thomas Simunich; Shawna Morrissey; Russell Dumire
Journal:  Eur J Trauma Emerg Surg       Date:  2018-01-06       Impact factor: 3.693

3.  Healing time of incision infection after hepatobiliary surgery treated by needle-free incision suture closure.

Authors:  Wen-Jie Ma; Yong Zhou; Hui Mao; Rui-Hua Xu; Anuj Shrestha; Fu-Yu Li; Alex Lorance; Qin Yang; Yong-Qiong Zhang; Ting Jiang; Huan Feng; Wei Zhang; Nan-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Prevention of surgical site infections in bone and joint procedures.

Authors:  Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

5.  Chitosan sponges for local synergistic infection therapy: a pilot study.

Authors:  J Keaton Smith; Abteen R Moshref; Jessica A Jennings; Harry S Courtney; Warren O Haggard
Journal:  Clin Orthop Relat Res       Date:  2013-04-20       Impact factor: 4.176

6.  Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution.

Authors:  Michael Phillips; Andrew Rosenberg; Bo Shopsin; Germaine Cuff; Faith Skeete; Alycia Foti; Kandy Kraemer; Kenneth Inglima; Robert Press; Joseph Bosco
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05-21       Impact factor: 3.254

7.  Effect of multidimensional intervention to reduce surgical site infection rate after knee and hip arthroplasty.

Authors:  Samar Saeed Morsi; Abeer Omar; Gautam Hebbar; Mariam Al-Fadhli; Wafaa S Hamza
Journal:  Germs       Date:  2021-03-15

Review 8.  Prevention of Periprosthetic Joint Infection.

Authors:  Alisina Shahi; Javad Parvizi
Journal:  Arch Bone Jt Surg       Date:  2015-04

9.  Ambulatory screening and decontamination to prevent Staphylococcus aureus complications in patients undergoing elective surgery (STAUfrei): study protocol for a controlled intervention study.

Authors:  Antonia Bauer; Martin Grünewald; Hans Eberhardt; Rieke Schulz; Peter Martus; Bernd Brüggenjürgen; Stefanie Joos; Heidrun Sturm
Journal:  BMC Infect Dis       Date:  2020-01-31       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.